BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9391185)

  • 1. Revisiting the prognostic role of gallium scintigraphy in low-grade non-Hodgkin's lymphoma.
    Gallamini A; Biggi A; Fruttero A; Pugno F; Cavallero G; Pregno P; Grasso M; Farinelli C; Leone A; Gallo E
    Eur J Nucl Med; 1997 Dec; 24(12):1499-506. PubMed ID: 9391185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma.
    Ben-Haim S; Bar-Shalom R; Israel O; Haim N; Epelbaum R; Ben-Shachar M; Gaitini D; Kolodny GM; Front D
    J Clin Oncol; 1996 Jun; 14(6):1936-42. PubMed ID: 8656263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 67Ga scintigraphy in B-cell non-Hodgkin's lymphoma: correlation of 67Ga uptake with histology and transferrin receptor expression.
    Nejmeddine F; Raphael M; Martin A; Le Roux G; Moretti JL; Caillat-Vigneron N
    J Nucl Med; 1999 Jan; 40(1):40-5. PubMed ID: 9935054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
    Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
    Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
    Wirth A; Seymour JF; Hicks RJ; Ware R; Fisher R; Prince M; MacManus MP; Ryan G; Januszewicz H; Wolf M
    Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
    Larcos G; Farlow DC; Antico VF; Gruenewald SM; Boyages J
    Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy.
    Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
    Radiology; 2000 Jan; 214(1):253-7. PubMed ID: 10644133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
    Waxman AD; Eller D; Ashook G; Ramanna L; Brachman M; Heifetz L; McAndrews P; Bierman H; Taub R; Avedo M; Wall F
    J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [SPECT-CT 67Ga studies in lymphoma disease. Contribution to staging and follow-up].
    Fuertes Manuel J; Estorch Cabrera M; Camacho Martí V; Flotats Giralt A; Rodríguez-Revuelto AA; Hernández Fructuoso MA; Carrió Gasset I
    Rev Esp Med Nucl; 2006; 25(4):242-9. PubMed ID: 16827987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the gallium scan in primary extranodal lymphoma.
    Hussain R; Christie DR; Gebski V; Barton MB; Gruenewald SM
    J Nucl Med; 1998 Jan; 39(1):95-8. PubMed ID: 9443744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin's lymphoma.
    Gasparini M; Bombardieri E; Castellani M; Tondini C; Maffioli L; Devizzi L; Gerundini P
    J Nucl Med; 1998 Sep; 39(9):1586-90. PubMed ID: 9744348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does gallium uptake in the pulmonary hila predict involvement by non-Hodgkin's lymphoma?
    Champion PE; Groshar D; Hooper HR; Palmer M; Catz Z; Belch A; McEwan A
    Nucl Med Commun; 1992 Oct; 13(10):730-7. PubMed ID: 1491837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of carbon-11 methionine positron emission tomography to assess malignancy grade and predict survival in patients with lymphomas.
    Nuutinen J; Leskinen S; Lindholm P; Söderström KO; Någren K; Huhtala S; Minn H
    Eur J Nucl Med; 1998 Jul; 25(7):729-35. PubMed ID: 9662595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of flow cytometric parameters and transferrin receptors with gallium-67 scintigraphic images in lymphoma patients.
    Kiratli PO; Canpinar H; Ruacan S; Kansu E
    Nucl Med Commun; 2000 Oct; 21(10):925-31. PubMed ID: 11130333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphoma.
    Ulusakarya A; Lumbroso J; Casiraghi O; Koscielny S; Vantelon JM; Girinsky T; Tardivon A; Bourhis JH; Dartevelle P; Pico JL; Munck JN
    Leuk Lymphoma; 1999 Nov; 35(5-6):579-86. PubMed ID: 10609795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
    Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
    Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
    Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
    J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18FDG positron emission tomography versus 67Ga scintigraphy as prognostic test during chemotherapy for non-Hodgkin's lymphoma.
    Zijlstra JM; Hoekstra OS; Raijmakers PG; Comans EF; van der Hoeven JJ; Teule GJ; Jonkhoff AR; v Tinteren H; Lammertsma AA; Huijgens PC
    Br J Haematol; 2003 Nov; 123(3):454-62. PubMed ID: 14617005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy.
    Brenot-Rossi I; Bouabdallah R; Di Stefano D; Bardou VJ; Stoppa AM; Camerlo J; Sauvan R; Gastaut JA; Pasquier J
    Eur J Nucl Med; 2001 Oct; 28(10):1482-8. PubMed ID: 11685490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.